Complement-mediated Inhibition of Adiponectin Regulates Perivascular Inflammation and Vascular Injury in Hypertension.

Cheng-Chao Ruan,Yu Ma,Qian Ge,Yan Li,Li-Min Zhu,Ying Zhang,Ling-Ran Kong,Qi-Hong Wu,Fanghong Li,Lixian Cheng,Allan Z. Zhao,Ding-Liang Zhu,Ping-Jin Gao
DOI: https://doi.org/10.1096/fj.201600780r
2016-01-01
Abstract:Perivascular adipose tissue (PVAT)-derived adiponectin (APN) is a secreted adipokine that protects against hypertension-related cardiovascular injury. However, the regulation of APN expression in hypertension remains to be explored. In this study, we demonstrated that down-regulation of APN was associated with complement activation in the PVAT of desoxycorticosterone acetate (DOCA)-salt hypertensive mice. Complement 3-deficient hypertensive mice were protected from ANP decrease in the PVAT. APN deficiency blockaded the protective effects of complement inhibition against hypertensive vascular injury. Mechanistically, complement 5a (C5a)-induced TNF-alpha secretion from macrophages is required for inhibiting APN expression in adipocytes. Macrophage depletion reversed C5a agonist peptide-induced TNF-alpha up-regulation and APN down-regulation in the PVAT of DOCA mice. Moreover, we detected increased macrophage infiltration and C5a expression associated with decreased APN expression in adipose tissue from patients with aldosterone-producing adenoma. These results identify a novel interaction between macrophages and adipocytes in the PVAT, where complement-mediated inhibition of APN acts as a potential risk factor for hypertensive vascular inflammation.
What problem does this paper attempt to address?